Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
เนื้อหาจัดทำโดย Proactive Investors เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Proactive Investors หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Player FM - แอป Podcast
ออฟไลน์ด้วยแอป Player FM !
ออฟไลน์ด้วยแอป Player FM !
BioHarvest Sciences Q2 Revenue Surpasses $6 Million; CEO Discusses Growth and New Product Success
MP3•หน้าโฮมของตอน
Manage episode 436900529 series 2891889
เนื้อหาจัดทำโดย Proactive Investors เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Proactive Investors หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to discuss the company’s impressive financial and operational results for the second quarter of 2024. For the first time, BioHarvest Sciences reported revenue surpassing the $6 million mark, reaching $6.03 million. This represents a 119% increase compared to the $2.8 million reported in the same quarter the previous year, and a 13% sequential growth from the first quarter of 2024. Sobel highlighted that the company's gross margins improved to 52% in the second quarter, up from 40% in the same period the previous year. This improvement is attributed to ongoing margin optimization efforts. In the U.S., total subscribers to the VINIA® product line increased by 135% compared to the same quarter in the previous year. A major contributor to this growth was the VINIA business, which set a new record for monthly sales orders in May 2024, achieving $2 million in sales—a 101% increase compared to May 2023. The company anticipates that revenues in the third quarter of 2024 will be at least $6.5 million. Additionally, Sobel shared exciting news about the company's VINIA® Superfood Coffee and Decaf Coffee. This "functional" coffee product line, which integrates BioHarvest's VINIA Red Grape Superfood into a premium coffee in Keurig-compatible pod format, has surpassed $1 million in cumulative sales since its launch in December 2023. The company is also planning to introduce new Nespresso-compatible pods before the end of the year, further expanding its product offerings and market reach. #proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #FinancialResults, #MarketingEfficiency, #ProductLaunch, #CoffeeProducts, #TeaProducts, #BusinessGrowth, #InvestorInterest, #BusinessStrategy, #FinancialForecast, #MarketExpansion, #CorporateDevelopment, #ManagementFocus, #EarningsReport, #StockMarket, #InvestmentOpportunity, #CorporateNews
…
continue reading
605 ตอน
MP3•หน้าโฮมของตอน
Manage episode 436900529 series 2891889
เนื้อหาจัดทำโดย Proactive Investors เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Proactive Investors หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to discuss the company’s impressive financial and operational results for the second quarter of 2024. For the first time, BioHarvest Sciences reported revenue surpassing the $6 million mark, reaching $6.03 million. This represents a 119% increase compared to the $2.8 million reported in the same quarter the previous year, and a 13% sequential growth from the first quarter of 2024. Sobel highlighted that the company's gross margins improved to 52% in the second quarter, up from 40% in the same period the previous year. This improvement is attributed to ongoing margin optimization efforts. In the U.S., total subscribers to the VINIA® product line increased by 135% compared to the same quarter in the previous year. A major contributor to this growth was the VINIA business, which set a new record for monthly sales orders in May 2024, achieving $2 million in sales—a 101% increase compared to May 2023. The company anticipates that revenues in the third quarter of 2024 will be at least $6.5 million. Additionally, Sobel shared exciting news about the company's VINIA® Superfood Coffee and Decaf Coffee. This "functional" coffee product line, which integrates BioHarvest's VINIA Red Grape Superfood into a premium coffee in Keurig-compatible pod format, has surpassed $1 million in cumulative sales since its launch in December 2023. The company is also planning to introduce new Nespresso-compatible pods before the end of the year, further expanding its product offerings and market reach. #proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #FinancialResults, #MarketingEfficiency, #ProductLaunch, #CoffeeProducts, #TeaProducts, #BusinessGrowth, #InvestorInterest, #BusinessStrategy, #FinancialForecast, #MarketExpansion, #CorporateDevelopment, #ManagementFocus, #EarningsReport, #StockMarket, #InvestmentOpportunity, #CorporateNews
…
continue reading
605 ตอน
Todos os episódios
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ